Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Body Map Reveals Widespread Pain in Chronic Pancreatitis

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and abdominal pain and is linked to more severe pain.

India Drug Regulator Tightens Surveillance Against Unauthorised Weight-loss Drug Sales

India's drug regulator has tightened surveillance against the unauthorised sale and promotion of weight-loss drugs, the health ⁠ministry said on Tuesday, after local...

Metabolically Healthy Obesity in Kids May Raise Disease Risk

Children with metabolically healthy obesity face higher risks for type 2 diabetes and dyslipidemia by 30 years of age than children in the general population.

College Behavior Influences Lifestyle, Weight, Decades Later

Unhealthy eating habits in college persist into early adulthood, a decade or more later, and are linked to greater weight gain, results from a longitudinal study show.

Long-Term Steroid Use Linked to Adrenal Insufficiency

Long-term use of systemic corticosteroids is linked to adrenal insufficiency and related hospitalisation, whereas long-term use of inhaled corticosteroids is modestly linked to adrenal insufficiency.

New Drug Shows Promise for Menopausal Hot Flushes and Sleep

Elinzanetant demonstrates superior or comparable efficacy to existing non-hormonal treatments in reducing the frequency of menopausal hot flushes while significantly improving sleep.

Todays Updates

From Pathology to Precision: The Story of Leukemia Therapy

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care evolved from near-certain death to precise, life-extending therapies.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Pegfilgrastim helps prevent myelosuppression in women undergoing chemotherapy for breast cancer but can also cause severe bone pain. A new study suggests a simple solution.

Todays Updates

From Pathology to Precision: The Story of Leukemia Therapy

From 19th century ‘white blood’ observations and pathological anatomy to the discovery of BCR-ABL and imatinib, leukemia care evolved from near-certain death to precise, life-extending therapies.

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Pegfilgrastim helps prevent myelosuppression in women undergoing chemotherapy for breast cancer but can also cause severe bone pain. A new study suggests a simple solution.

Latest News

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and abdominal pain and is linked to more severe pain.

India's drug regulator has tightened surveillance against the unauthorised sale and promotion of weight-loss drugs, the health ⁠ministry said on Tuesday, after local...

Children with metabolically healthy obesity face higher risks for type 2 diabetes and dyslipidemia by 30 years of age than children in the general population.

Unhealthy eating habits in college persist into early adulthood, a decade or more later, and are linked to greater weight gain, results from a longitudinal study show.

Long-term use of systemic corticosteroids is linked to adrenal insufficiency and related hospitalisation, whereas long-term use of inhaled corticosteroids is modestly linked to adrenal insufficiency.

Elinzanetant demonstrates superior or comparable efficacy to existing non-hormonal treatments in reducing the frequency of menopausal hot flushes while significantly improving sleep.

News All Time

Frequent Insulin Infusion Site Failures ‘a Huge Problem’

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

GLP-1s Tied to Lower Risk of Psychiatric Decline

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A1c or CGM Metrics: Which Should Be the Gold Standard?

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Four-Drug Regimen Superior to Escalating Metformin in T2D

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

Keto Diet Boosts Aerobic Fitness in Hyperglycemic Mice

In hyperglycemic male mice, a ketogenic diet normalizes blood glucose and restores response to aerobic training.

Female Survival Advantage Narrows in Midlife Due to Cancer

A new cohort study finds that female reproductive cancers are a major cause of deaths in women aged 35-60 years, and eliminating these cancers would widen the known survival gap between sexes.

FDA Okays Higher-Dose Wegovy Injection for Weight Loss

The approval is part of a new FDA pilot program.

Australian Private Health Insurers Are Buying Up GP Clinics

Vertical integration is likely to reduce patient choice, restrict doctors’ referrals and prescriptions, and increase costs in the long term, critics say.

GLP-1s Linked to Lower Mortality in Patients With Brain Mets

Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, new data suggest.

Osteoarthritis Knee Pain Impairs Diabetes Glycemic Control

New research hints at a connection between knee pain and glycemic results, but more research is needed.

Inpatient Glucose Testing Triples Postpartum Screening

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.

GLP-1s a Viable Option to Treat, Prevent SUDs?

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Structure's Obesity Pill Shows Up to 16.3% Weight Loss in Study

Structure Therapeutics said on Monday its pill helped patients lose up to 16.3% of their weight, strengthening ⁠its bid to challenge Eli Lilly and Novo Nordisk in the...

Upcoming Guidance to Address GLP Drugs in Type 1 Diabetes

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

Pancreatic Enzyme Replacement Therapy for GLP-1 Symptoms?

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

Recommended News For You

Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

A small rise in cancer was observed following the 1986 Chernobyl accident.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Brain cancer: a Q&A session.

Home Screening Appeals to Women Facing Healthcare Barriers

Recommended Articles For You

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk 

The Latest Research on Wiskott Aldrich Syndrome  

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

2.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

3.

Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.

4.

Rural-urban disparities seen in cervical cancer

5.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

1.

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape

2.

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma

3.

Everything You Need to Know About HTLV: A Comprehensive Guide 

4.

Exploring the Mysteries of Myxoma: A New Frontier in Medical Research

5.

Cancer Rates on the Rise: What Can We Do to Stop It?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Current Scenario of Cancer- Q&A Session to Close the Gap

4.

Updates on Standard V/S High Risk Myeloma Treatment

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot